DANIEL M WITT portrait
  • Department Chair, Pharmacotherapy
  • Professor, Pharmacotherapy
  • Professor, Pharmacotherapy

Education

  • Associate of Science, General Studies, Snow College, Ephraim, Utah
  • Bachelor of Science, Pharmacy, University of Utah, Salt Lake City, Utah
  • Clinical Pharmacy Residency, University of Washington and Harborview Medical Centers, Seattle, Washington
  • Doctor of Pharmacy, Pharmacy, University of Washington, Seattle, Washington. Project: Interaction between glipizide and co-trimoxazole
  • Advanced Residency, Primary Care and Family Medicine, University of Washington, Seattle, Washington

Biography

Daniel M. Witt, Pharm.D., FCCP, BCPS is Professor (Clinical) and Vice Chair of the Department of Pharmacotherapy at the University of Utah College of Pharmacy.  He received the B.S. degree in pharmacy from the University of Utah and the PharmD degree from the University of Washington.  He completed a Clinical Pharmacy Residency at the University of Washington and Harborview Medical Centers, Seattle, WA and an Advanced Residency in Primary Care and Family Medicine, University of Washington.  Dr. Witt has authored or co-authored over 90 journal articles, 11 book chapters, and given numerous lectures for continuing education programs. His research interests center on providing practical information regarding the optimal use of anticoagulation therapy to front-line practitioners and patients. He was a panel member for the 2012 CHEST Consensus Guidelines for Antithrombotic therapy and is currently serving as a panel member for venous thromboembolism guidelines being developed by the American Society of Hematology. Dr. Witt also serves on the Board of Directors for the Anticoagulation Forum and is a member of the American College of Clinical Pharmacy, American Society of Health-Systems Pharmacists and the International Society on Thrombosis and Haemostasis.

Research Interests

I have been actively involved in designing and conducting research projects for more than 30 years, with the principal areas of focus being 1) documentation of the clinical and economic impact of clinical pharmacy services; 2) providing optimized management of anticoagulation therapy; and 3) providing practical evidence-based solutions to contemporary dilemmas encountered by anticoagulation therapy providers in clinical practice. I joined the faculty at the University of Utah College of Pharmacy in large part to expand anticoagulation therapy research opportunities, foster additional collaborative research relationships and teams, and expand my opportunities to mentor investigators in training. In addition, I have strong relationships with researchers from Kaiser Permanente Colorado, the Veterans Administration, McMaster University, the University of Michigan, Brigham and Women’s Hospital, and the University of Utah.